Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Valhalla Vitality vs Wisp

Valhalla Vitality
Graded #253

Lower grade

vs+0.8000000000000043
Wisp
Graded #243

Higher grade

The verdict

Wisp takes it — 64.4/100 to 63.6/100, but only just.

Wisp grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Wisp (hellowisp.com) is a US telehealth provider whose weight care vertical offers brand-name Wegovy, Zepbound, and Saxenda alongside a compounded sublingual semaglutide drops formulation at $225/month. Valhalla Vitality is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueWisp +14
36
50
Dose & formulationWisp +12
64
76
Clinical oversightEven
82
82
Labs & monitoringValhalla Vitality +30
83
53
FulfillmentValhalla Vitality +1
67
66
Contract termsValhalla Vitality +6
61
55
Valhalla Vitality · left barWisp · right bar

The numbers

MetricValhalla VitalityWisp
WeighScore63.6/10064.4/100
GradeCC
Scorecard rank#253#243
Semaglutide$449/mo (compounded)$225/mo (compounded oral)
Tirzepatide$449/mo (compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Valhalla Vitality

Graded #253 · C

Strengths

  • LegitScript-certified pharmacy partner
  • Offers both compounded semaglutide and tirzepatide
  • No membership fees and free consultations
  • Add-on peptide and hormone therapies plus at-home labs

Where it loses points

  • Compounded GLP-1 only, no FDA-approved branded options
  • Pricing not transparently listed on the main site
  • Compounded drugs are not FDA-approved for safety or efficacy
  • States served not clearly disclosed
Wisp

Graded #243 · C

Strengths

  • Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
  • LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
  • Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary

Where it loses points

  • The $99/mo tirzepatide figure is a consultation-and-care subscription, not the medication: Zepbound is filled at a pharmacy of your choice at its own cost, which Wisp does not publish
  • The compounded semaglutide option is sublingual drops, which Wisp itself describes as less effective than injection
  • Brand-name access is a prescription, not a dispensed product, so the drug cost is outside anything quoted here

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard